recommend narrow-spectrum penicillins ( penicillin, ampicillin, amoxicillin) for children hospitalized with uncomplicated pneumonia. Prior to guideline release, most hospitalized children received second/third generation cephalosporins. We assessed the impact of the national guideline and subsequent hospital-level interventions on antibiotic choice across a national sample.
Methods. We identified children 6 months to 18 years from 28 children's hospitals admitted between August 2009 and March 2015 with a diagnosis of pneumonia and who received antibiotics within the first 2 hospital days. Each hospital was surveyed regarding local activities implemented after guideline release (e.g. clinical practice guideline [CPG] ). Outcomes included the monthly percentage of children receiving penicillins or cephalosporins. Interrupted time series analysis was used to assess the national guideline impact by comparing the absolute change in prescribing at the end of the study ([observed % from post-guideline trend] -[expected % from preguideline trend]) aggregated across all hospitals. Hospital-level analyses assessed the impact of local activities.
Results. A total of 58,559 pneumonia hospitalizations were included. Prior to the national guideline, penicillin use was rare (<10%); cephalosporins accounted for ∼60% of prescribing. After guideline release, 19 hospitals (68%) implemented a new CPG and 20 (71%) implemented a new order set. By the end of the study and compared with pre-guideline trends, we noted an absolute increase in penicillin use of 27.6% (95% CI: 23.7%-31.5%) [ Figure 1 ]. Cephalosporin use declined by a similar magnitude (not shown). Prescribing changes varied across hospitals [ Figure 2 ]. Among hospitals implementing a CPG or order set, the median difference was 29.5 [IQR 19.6, 39 .1] for penicillins, while among hospitals without local activities, the median difference was 20.1 [9.5, 44.5]; these differences were not statistically significant. 
Conclusion

